MedPath

Is a Smartphone Application Effective as an Oral Medication Adherence Aid

Early Phase 1
Terminated
Conditions
Diabetes
Dyslipidemia
Hypertension
Interventions
Other: Medication Adherence Smartphone App
Registration Number
NCT01968876
Lead Sponsor
University of Arkansas
Brief Summary

This research will act as a pilot study that will be conducted to determine the effectiveness of a smartphone medication adherence application on adherence to oral hypertensive, diabetic, and dyslipidemic medications using a prospective randomized design. Subjects will be recruited from the University of Arkansas for Medical Sciences (UAMS) Internal Medicine Clinic North, and the study data will be collected using only subject self-reports and subject pharmacy records.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Males and females at least 18 years of age
  • Provide informed consent
  • Prescribed an oral medication indicated for hypertension, diabetes, or dyslipidemia during 12 weeks pre-enrollment
  • Own a smartphone (Android or iOS) with unlimited text messaging, email access, and app store access
  • Oral confirmation that the subject has not previously used a medication adherence app
  • Able to consult with a pharmacy or medical student during the recruitment process for purposes of consent, data collection, and/or medication reconciliation, and/or MyMedSchedule registration
Exclusion Criteria
  • Severely impaired vision
  • Reside in a nursing home
  • Non-ambulatory/bedridden
  • Not fluent in English

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Medication Adherence Smartphone AppMedication Adherence Smartphone AppThe experimental group will receive the medication adherence app on their smartphone and will have their entire outpatient medication list pushed to the application. Text message reminders will be sent to their phones at the appropriate times.
Primary Outcome Measures
NameTimeMethod
Change from baseline in number of pills taken over number of pills prescribed at 4 weeksChange from baseline to 4 weeks
Change from baseline in number of pills taken over number of pills prescribed at 12 weeksChange from baseline to 12 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Remedy Drug

🇺🇸

Little Rock, Arkansas, United States

Internal Medicine Clinic West; University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

Internal Medicine Clinic North; University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath